At VBreathe we partner with leading businesses to provide their employees with exclusive discounts on VBreathe Tasman. This can sit alongside existing employee benefit and recognition programs, or be delivered as a bespoke solution.
No cost or setup required.
We provide co-branded assets to communicate the exclusive offer to staff via intranet, newsletter, mobile apps, posters and more.
You will receive:
Ready to get started? Get in touch today!
To find out more send us a message to [email protected]
or complete the form.
COVID-19 VIRUS REPORT
Eurofins Laboratories found VBreathe capable of reducing a strand of coronavirus with 99.9% efficiency. This strand of coronavirus is accepted by the TGA (Therapeutic Goods Administration) as a surrogate for COVID-19.
Reduction in the following Bacteria:
Staphylococcus aureus - 99.9%
E. coli - 99.9999%
Pseudomonas aeruginosa - 90%
Enterococcus hirae - 99.999%
NASAL AND LUNG REPORT
As per ISO 10993-5:2009 standards, the VBreathe Tasman’s controlled aerosolised droplets (vapours) are not toxic and do not adversely affect nasal and lung epithelial cells.
88% reduction in the mould count within 24 hours and after 3 days there was a 95% reduction.
AIR QUALITY REPORT
In 60 minutes, concentration of 1 Micron and 2.5 Micron particles were reduced by 97% and 96% respectively.
Safe to be used in food preperation areas.
Please select your region/currency:Australia (AUD) Denmark (kr) Netherlands (EUR) Norway (kr) Sweden (kr) Poland (zł) Finland (EUR)